
IL-38 as a Novel Biomarker in Multiple Myeloma Patients: A Prospective Clinical Evaluation
Introduction Characterised by “CRAB” symptoms, elevated calcium levels, renal insufficiency, anemia, and bone disease, MM is a severe systemic disease. It manifests in diverse forms, including secondary amyloidosis.1 Despite the fact that chemotherapy and …